This brain scan company told me I have the makings of a CEO

"Have you heard of the movie 'Gattaca?'"

Brain scan helmet

Wave Neuro can measure brain waves to determine employees' strengths and weaknesses.

Photo: Wave Neuro

It is Wednesday morning, and I am about to have my brain scanned.

I’m at The Well, a wellness center in Manhattan that resembles a cross between a fancy coffee shop and a Goop store. It looks like the kind of place that sells Himalayan salt lamps, essential oils and maybe also has cryotherapy or float pods in the back.

Inside, I meet a PR person, also named Michelle, who works for Wave Neuroscience, the company that invited me to have my brain scanned. According to the press kit she had sent me, Wave Neuro has developed a first-of-its-kind “personal Braincare device” and brain analysis that could answer such relevant workplace questions as, “Is that micromanager just wired that way?” and “How can you adapt your work habits to better fit your brain?”

Michelle leads me through an underground passageway with a wall covered in geodes and into a small room that looks like an exam room at a doctor’s office, but with spa lighting. Waiting inside is a Wave Neuro employee named Jay who’s dressed in blue scrubs. On the exam table I see equipment that I will later learn is designed for quantitative electroencephalogram (qEEG) and electrocardiogram (EKG) tests.

Jay puts the EEG device on my head and attaches sticky wires for the EKG to my chest. He fiddles with the knobs, tightening them so that the device fits squarely on my skull. Then he instructs me to sit still with my eyes closed for 10 minutes while the EEG scans my brain.

“Should I think about anything specific?” I ask. “No,” he says. “Just don’t meditate, and don’t fall asleep.” According to Jay, really good meditators can mess with the results of the scan. I promise not to meditate. Then I remember I haven’t had my morning coffee yet, and I will myself to stay awake.

 Michelle Ma in brain scan helmetThe scan takes 10 minutes.Photos: Michelle Ma/Protocol

We sit in a companionable silence for 10 minutes; when it’s over, he takes the device off my head, and I’m led back aboveground. Waiting for me in the coffee shop section of the wellness space is Alex Ring, the company’s director of Applied Sciences. In front of him is a laptop with my brain scan results. Next to us is the Sonal machine, the day’s main attraction.

Before I go any further, it would be useful to understand how this is all supposed to work: QEEG and EKG are standard tests used commonly in medical settings across the world to measure electrical signals in the brain and heart. The Sonal machine on the table in front of us is a proprietary device from Wave Neuro that claims to use “cutting-edge, non-invasive technology that reshapes your brainwaves to effectively improve your brain health for general well-being.” After the initial brain scan, Wave Neuro generates a one-page summary that interprets your brainwave recording compared to people of a similar age and gender.

That report is used to prescribe a course of action to improve brain function using the Sonal device, typically with “Brain Stimulation” sessions that take place for 30 minutes a day, five days a week, for about a month. Wave Neuro claims these treatments can improve sleep, mood and focus.

It is time to look at my results. First, Ring shows me my brain waves on his laptop screen. As an untrained brain-scan reader, I have no idea what I'm looking at. They look like EKG lines that track heart activity, but for my brain. Then he pulls up the one-page PDF summary.

The biggest number I see up top is my “Brainwave Synchrony Score” of 77.27%. Then, below that, a few other numbers, including my brain’s speed (10.47 Hz) and its optimal range (11 to 12 Hz). (I think again of the coffee that I didn’t have that morning. Could that have influenced my score? No, he reassures me.)

The more interesting part is my “Performance Summary.” According to Wave Neuro’s summary of my brain scan, my strengths include “superior processing skills [and] capability to focus under pressure” as well as “cognitive flexibility.” My weaknesses, kindly framed as “opportunities,” include “potential for enhanced stress management” and “improvements in self-reflection.”

Ring points out the shape of my brain waves and what he calls alpha and beta activity. Alpha waves are slower and larger and generally correspond to a relaxed state, while beta waves are smaller and faster and are associated with concentration and intellectual activity.

“What would you want to see in someone who’s a CEO?” I ask.

Generally, he explains, CEOs have high amounts of beta activity. “It’s very difficult for them to slow down,” he says, since “they have to track every part of the business.” But they still want a healthy amount of alpha, because they need to be able to stop and listen. “So a profile similar to yours,” he says, looking back up at me.

I ask him, based on my results, what kind of job he thinks I would be suited for.

Based on my scan, I have a brain that’s “really flexible,” he says. “There are some people who are definitely engineers, right? And then there are some people who definitely should not be engineers, so to speak,” he adds.

I continue peppering him with questions. What would an engineer’s brain look like? An artist’s? What about a corporate leader’s? His answers are measured. To look for leaders with only one kind of brain would be a detriment to corporate culture: “You want a diversity of brain styles and thinking,” he says. And people who aren’t “built” to be engineers and end up working in engineering “are going to bring new perspectives,” so it wouldn’t be fair to pigeonhole someone based on their brain’s strengths and weaknesses.

Screenshot of Wave Neuro resultsThe brain scan results put my synchrony score at a 77.27%.Image: Wave Neuro

I ask him if he sees a future where companies use brain scans in an evaluatory capacity, to screen job candidates and, say, only hire people whose scores are over 80%. “Have you heard of the movie ‘Gattaca?’” he asks. I nod. “It’s my favorite movie,” he says, seriously.

Ring tells me it’s absolutely not the company’s objective to replicate the “Gattaca” scenario: a dystopian future of genetic discrimination driven by eugenics. In the film, Ethan Hawke plays protagonist Vincent Freeman, an “in-valid” person who’s relegated to working a menial job cleaning offices despite his dreams of working in space travel due to his genetic makeup.

Wave Neuro’s true goal, according to director of Strategic Relations Spencer Vigoren, is a lofty one: “to democratize brain care,” making devices and tests once reserved for the medical community available for the masses, and providing an understandable, actionable summary of the brain for any curious layperson who is willing to shell out for it. The scan is just the beginning. The Sonal is the star of the show, with the potential to change people’s brains and improve their lives permanently, he says.

Ring’s brainwave synchrony score is in the 80s, he tells me. Before going through Sonal treatment, it was lower. Is the goal to raise that score? “Yes,” he says. I ask what it means for his brain to have a higher score.

He says that, for him personally, it means that he can focus better. He has a 1.5-year-old boy at home and his wife frequently, jokingly, refers to his “dad brain,” a consequence of not getting adequate sleep for six months. After using the Sonal, he says, “I feel better than I did pre-kid.”

Here’s the kicker: The device itself costs $6,000. Vigoren tells me he sees a future in which companies buy the device for their employees to make them “more easily capable of concentration” as well as to improve their interactions with their co-workers. According to him, Wave Neuro is already working with “a couple of companies in Washington that make software” whose engineers aren’t sleeping well. “From a company wellness management perspective, it’s a really great application,” Vigoren says.

I ask which specific companies, and he refuses to name them. According to him, so far they’ve pre-sold about a thousand Sonal devices.

Wave Neuro’s treatments and the Sonal device itself are not approved by the FDA as medical devices. The company’s Terms and Conditions page is littered with qualifications: Users shouldn’t construe, rely upon or interpret the EEG report as providing any medical advice. The company makes no representations that Sonal will provide any therapeutic benefits, and it’s not intended to diagnose, treat, cure or prevent any medical condition. It’s simply “a wellness device intended to encourage and inform healthy lifestyle choices.”

I think of all the expensive, lofty propositions that have popped up over the years aimed at this ever-elusive goal: wellness. What is wellness? Is it a stand-in for mental and physical health? Is it something that can be achieved, or is it just a funnel for our modern-day anxieties, our never-satiated desires to improve, optimize and transport ourselves to an unreachable destination?

Time will tell, but for now, my brainwave synchrony score will stay at a perfectly adequate 77.27%. But at least I still have the makings of a CEO, or so I’ve been told.


Judge Zia Faruqui is trying to teach you crypto, one ‘SNL’ reference at a time

His decisions on major cryptocurrency cases have quoted "The Big Lebowski," "SNL," and "Dr. Strangelove." That’s because he wants you — yes, you — to read them.

The ways Zia Faruqui (right) has weighed on cases that have come before him can give lawyers clues as to what legal frameworks will pass muster.

Photo: Carolyn Van Houten/The Washington Post via Getty Images

“Cryptocurrency and related software analytics tools are ‘The wave of the future, Dude. One hundred percent electronic.’”

That’s not a quote from "The Big Lebowski" — at least, not directly. It’s a quote from a Washington, D.C., district court memorandum opinion on the role cryptocurrency analytics tools can play in government investigations. The author is Magistrate Judge Zia Faruqui.

Keep ReadingShow less
Veronica Irwin

Veronica Irwin (@vronirwin) is a San Francisco-based reporter at Protocol covering fintech. Previously she was at the San Francisco Examiner, covering tech from a hyper-local angle. Before that, her byline was featured in SF Weekly, The Nation, Techworker, Ms. Magazine and The Frisc.

The financial technology transformation is driving competition, creating consumer choice, and shaping the future of finance. Hear from seven fintech leaders who are reshaping the future of finance, and join the inaugural Financial Technology Association Fintech Summit to learn more.

Keep ReadingShow less
The Financial Technology Association (FTA) represents industry leaders shaping the future of finance. We champion the power of technology-centered financial services and advocate for the modernization of financial regulation to support inclusion and responsible innovation.

AWS CEO: The cloud isn’t just about technology

As AWS preps for its annual re:Invent conference, Adam Selipsky talks product strategy, support for hybrid environments, and the value of the cloud in uncertain economic times.

Photo: Noah Berger/Getty Images for Amazon Web Services

AWS is gearing up for re:Invent, its annual cloud computing conference where announcements this year are expected to focus on its end-to-end data strategy and delivering new industry-specific services.

It will be the second re:Invent with CEO Adam Selipsky as leader of the industry’s largest cloud provider after his return last year to AWS from data visualization company Tableau Software.

Keep ReadingShow less
Donna Goodison

Donna Goodison (@dgoodison) is Protocol's senior reporter focusing on enterprise infrastructure technology, from the 'Big 3' cloud computing providers to data centers. She previously covered the public cloud at CRN after 15 years as a business reporter for the Boston Herald. Based in Massachusetts, she also has worked as a Boston Globe freelancer, business reporter at the Boston Business Journal and real estate reporter at Banker & Tradesman after toiling at weekly newspapers.

Image: Protocol

We launched Protocol in February 2020 to cover the evolving power center of tech. It is with deep sadness that just under three years later, we are winding down the publication.

As of today, we will not publish any more stories. All of our newsletters, apart from our flagship, Source Code, will no longer be sent. Source Code will be published and sent for the next few weeks, but it will also close down in December.

Keep ReadingShow less
Bennett Richardson

Bennett Richardson ( @bennettrich) is the president of Protocol. Prior to joining Protocol in 2019, Bennett was executive director of global strategic partnerships at POLITICO, where he led strategic growth efforts including POLITICO's European expansion in Brussels and POLITICO's creative agency POLITICO Focus during his six years with the company. Prior to POLITICO, Bennett was co-founder and CMO of Hinge, the mobile dating company recently acquired by Match Group. Bennett began his career in digital and social brand marketing working with major brands across tech, energy, and health care at leading marketing and communications agencies including Edelman and GMMB. Bennett is originally from Portland, Maine, and received his bachelor's degree from Colgate University.


Why large enterprises struggle to find suitable platforms for MLops

As companies expand their use of AI beyond running just a few machine learning models, and as larger enterprises go from deploying hundreds of models to thousands and even millions of models, ML practitioners say that they have yet to find what they need from prepackaged MLops systems.

As companies expand their use of AI beyond running just a few machine learning models, ML practitioners say that they have yet to find what they need from prepackaged MLops systems.

Photo: artpartner-images via Getty Images

On any given day, Lily AI runs hundreds of machine learning models using computer vision and natural language processing that are customized for its retail and ecommerce clients to make website product recommendations, forecast demand, and plan merchandising. But this spring when the company was in the market for a machine learning operations platform to manage its expanding model roster, it wasn’t easy to find a suitable off-the-shelf system that could handle such a large number of models in deployment while also meeting other criteria.

Some MLops platforms are not well-suited for maintaining even more than 10 machine learning models when it comes to keeping track of data, navigating their user interfaces, or reporting capabilities, Matthew Nokleby, machine learning manager for Lily AI’s product intelligence team, told Protocol earlier this year. “The duct tape starts to show,” he said.

Keep ReadingShow less
Kate Kaye

Kate Kaye is an award-winning multimedia reporter digging deep and telling print, digital and audio stories. She covers AI and data for Protocol. Her reporting on AI and tech ethics issues has been published in OneZero, Fast Company, MIT Technology Review, CityLab, Ad Age and Digiday and heard on NPR. Kate is the creator of and is the author of "Campaign '08: A Turning Point for Digital Media," a book about how the 2008 presidential campaigns used digital media and data.

Latest Stories